Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 2Head & Neck 1Gynecologic 1Gastrointestinal 1Dermatologic 1

Conditions

Melanoma 62Lymphoma, T-Cell, Cutaneous 42Lymphoma, Follicular 37Lymphoma, B-Cell, Marginal Zone 37Leukemia, Lymphocytic, Chronic, B-Cell 37Precursor Cell Lymphoblastic Leukemia-Lymphoma 36Lymphoma, Non-Hodgkin 36Lymphoma, Mantle-Cell 35Sezary Syndrome 34Mycosis Fungoides 34Lymphoma, Large B-Cell, Diffuse 34Hodgkin Disease 33Multiple Myeloma 32Lymphoma, Large-Cell, Immunoblastic 32Leukemia, Myeloid, Acute 32Burkitt Lymphoma 32Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 30Congenital Abnormalities 30Leukemia, Myeloid, Accelerated Phase 27Leukemia, Myeloid, Chronic-Phase 26Waldenstrom Macroglobulinemia 25Lymphoma, Large-Cell, Anaplastic 25Lymphoma 25Myeloproliferative Disorders 24Lymphoma, Extranodal NK-T-Cell 24Leukemia 23Immunoblastic Lymphadenopathy 23Leukemia, Myelomonocytic, Chronic 21Recurrence 20Myelodysplastic Syndromes 19

Interventions

Cyclophosphamide 7fludarabine 4pembrolizumab 2fludarabine phosphate 1aldesleukin 1Radiation 1Quality of Life 1Patient Reported Outcome Measures 1Molecular Diagnostic Techniques 1Mass Spectrometry 1Leukapheresis 1Interleukin-2 1Injections 1Immunotherapy, Adoptive 1Immunotherapy 1Imatinib Mesylate 1Drug Therapy 1Decitabine 1Chromatography, High Pressure Liquid 1Biological Therapy 1BI 2536 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Sarcoma, Synovial × fludarabine phosphate × Dermatologic × Clear all
NCT02366546 2018-10-24

Investigator Initiated Phase 1 Study of TBI-1301

Mie University

Phase 1 Unknown
9 enrolled
DermatologicGastrointestinalGynecologicHead & NeckSarcoma

Esophageal Neoplasms, Head and Neck Neoplasms, Melanoma, Ovarian Neoplasms, Sarcoma, Synovial

Data powered by HemOnc (CC BY 4.0) Colophon âš¡